264 related articles for article (PubMed ID: 1677327)
1. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut.
Kreymann B; Ghatei MA; Domin J; Kanse S; Bloom SR
Endocrinology; 1991 Aug; 129(2):1001-5. PubMed ID: 1677327
[TBL] [Abstract][Full Text] [Related]
2. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
Heller RS; Aponte GW
Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
Inoue K; Hisatomi A; Umeda F; Nawata H
Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
5. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
[TBL] [Abstract][Full Text] [Related]
6. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas.
Göke R; Fehmann HC; Richter G; Trautmann M; Göke B
Pancreas; 1989; 4(6):668-73. PubMed ID: 2573056
[TBL] [Abstract][Full Text] [Related]
7. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide.
Komatsu R; Matsuyama T; Namba M; Watanabe N; Itoh H; Kono N; Tarui S
Diabetes; 1989 Jul; 38(7):902-5. PubMed ID: 2661287
[TBL] [Abstract][Full Text] [Related]
8. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.
Lovshin J; Yusta B; Iliopoulos I; Migirdicyan A; Dableh L; Brubaker PL; Drucker DJ
Endocrinology; 2000 Nov; 141(11):4194-201. PubMed ID: 11089553
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
[TBL] [Abstract][Full Text] [Related]
10. Identification of glucagon-like peptide-1(7-36) amide in rat brain.
Yoshimoto S; Hirota M; Ohboshi C; Shima K
Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():169-71. PubMed ID: 2729860
[TBL] [Abstract][Full Text] [Related]
11. Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas.
Philippe J; Mojsov S; Drucker DJ; Habener JF
Endocrinology; 1986 Dec; 119(6):2833-9. PubMed ID: 3536450
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K
Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616
[TBL] [Abstract][Full Text] [Related]
13. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro.
Guenifi A; Ahrén B; Abdel-Halim SM
Pancreas; 2001 Jan; 22(1):58-64. PubMed ID: 11138972
[TBL] [Abstract][Full Text] [Related]
15. Release of glucagon-like peptide 1 immunoreactivity from the perfused rat pancreas.
Shima K; Hirota M; Ohboshi C; Sato M; Nishino T
Acta Endocrinol (Copenh); 1987 Apr; 114(4):531-6. PubMed ID: 3577586
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures.
Chisholm C; Greenberg GR
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E311-7. PubMed ID: 12110536
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon.
Plaisancie P; Bernard C; Chayvialle JA; Cuber JC
Endocrinology; 1994 Dec; 135(6):2398-403. PubMed ID: 7988423
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.
Matsuyama T; Komatsu R; Namba M; Watanabe N; Itoh H; Tarui S
Diabetes Res Clin Pract; 1988 Oct; 5(4):281-4. PubMed ID: 3069410
[TBL] [Abstract][Full Text] [Related]
19. Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay.
van Delft J; Uttenthal LO; Hermida OG; Fontela T; Ghiglione M
Regul Pept; 1997 Jun; 70(2-3):191-8. PubMed ID: 9272633
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.
Wettergren A; Petersen H; Orskov C; Christiansen J; Sheikh SP; Holst JJ
Scand J Gastroenterol; 1994 Jun; 29(6):501-5. PubMed ID: 7915853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]